We are seeking an Executive Consultant – Vice President of Quantitative Clinical Pharmacology to join our Strategic Consulting team. This role blends scientific leadership, strategic advisory, client relationship development, and technical excellence in population modeling and quantitative clinical pharmacology. The successful candidate will leverage both deep quantitative expertise and strong business acumen to expand Cytel’s thought leadership, drive complex consulting engagements, and guide clients in shaping optimal regulatory and clinical development pathways.
ResponsibilitiesStrategic Consulting & Thought Leadership
- Serve as an externally recognized expert in Quantitative Clinical Pharmacology, Pop-PK/PK-PD modeling, MIDD, and quantitative regulatory strategies.
- Lead the development and dissemination of innovative methodologies, contributing to Cytel’s scientific leadership through publications, conference presentations, and webinars.
- Provide high-level strategic guidance to clients on clinical development plans, regulatory and market access pathways, trial design optimization, and quantitative decision-making.
Client Engagement & Business Development
- Act as the primary point of contact for major Strategic Consulting accounts, ensuring delivery excellence and long-term partnership development.
- Identify and pursue new business opportunities across Cytel’s consulting and analytics offerings, shaping solutions that meet revenue, profitability, and client satisfaction objectives.
- Build and maintain relationships with senior stakeholders, including regulatory agencies (e.g., FDA, EMA), key opinion leaders, and executive-level client personnel.
Scientific & Analytical Leadership
- Oversee and contribute to Pop-PK and PK/PD modeling, non-compartmental analysis (NCA), and broader QPP analytical activities.
- Provide mentorship, technical oversight, and direction to consultants and analysts, building a high-performing quantitative team.
- Support non-QPP engagements when needed, such as statistical design, adaptive/Bayesian methodologies, simulation-based planning, or data science initiatives.
Cross-Functional Collaboration
- Work closely with Cytel’s business developers, statisticians, software teams, and data scientists to deliver integrated, high-value solutions.
- Represent QPP expertise within multidisciplinary engagements, ensuring strategic alignment and scientific rigor.
- Travel as required to engage with clients and internal stakeholders.
Experience
- Minimum 5+ years of hands-on QPP experience; 15+ years overall experience in consulting, clinical development, or health research preferred for VP-level responsibilities.
- Demonstrated leadership in MIDD, Pop-PK/PK-PD modeling, and quantitative strategy within drug development.
- Experience interacting with regulatory authorities and contributing to regulatory submissions is highly desirable.
Required Technical & Professional Skills
- Proven expertise in Pop-PK/PK-PD modeling, NCA, and interpretation of quantitative pharmacology results for CSR and reporting.
- Proficiency in Phoenix WinNonlin/NLME, R, and strong understanding of computational and statistical methods used in clinical development.
- Excellent technical writing, oral communication, and presentation skills; ability to clearly communicate complex quantitative concepts.
- Strong organizational, analytical, and problem-solving abilities; able to operate effectively in a fast-paced, high-growth environment.
#LI-KO1
Skills Required
- Minimum 5 years of hands-on quantitative clinical pharmacology experience
- Expertise in Pop-PK and PK-PD modeling
- Expertise in non-compartmental analysis and interpretation of quantitative pharmacology results
- Proficiency in Phoenix WinNonlin and NLME
- Proficiency in R
- Strong understanding of computational and statistical methods used in clinical development
- Excellent technical writing, oral communication, and presentation skills
- Strong organizational, analytical, and problem-solving abilities
- Ability to operate effectively in a fast-paced, high-growth environment
- 15 or more years of overall experience in consulting, clinical development, or health research
- Leadership in MIDD, Pop-PK/PK-PD modeling, and quantitative strategy within drug development
- Experience interacting with regulatory authorities and contributing to regulatory submissions
Cytel Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Cytel and has not been reviewed or approved by Cytel.
-
Healthcare Strength — Health coverage is described as comprehensive, spanning medical, dental, vision, life and disability, with FSAs/HSAs also available. Plan quality is often characterized as good to excellent, which lifts the perceived value of the overall package.
-
Retirement Support — A 401(k) with employer match is consistently part of the benefits package. The plan is also characterized as well managed, contributing to a sense of baseline retirement support.
-
Fair & Transparent Compensation — Overall pay is characterized as decent-to-good and broadly competitive in parts of the business, with stronger alignment noted in senior technical tracks like biostatistics and programming. The total package is often framed as respectable rather than premium.
Cytel Insights
What We Do
Cytel enables decision-makers in the life sciences to unlock the full potential of their products. From navigating uncertainty to proving value, Cytel’s 30 years of global expertise in consulting, data-driven analytics, and industry-leading software helps biotech and pharmaceutical companies transform intelligence into confident decisions. We have an uncompromising commitment to scientific rigor and high standards of operational excellence, which are channeled through our locations in North America, Europe, the United Kingdom, and Asia. Together, we enable our clients to deliver the therapies that propel humanity forward. Cytel employs a range of data science tools from biostatistics to machine learning to help executives in the life-sciences to make confident decisions powered by data. We are probably best known for being leaders in the field of adaptive clinical trial design, a subset of trial design that uses interim looks to enhance the patient safety and commercial value of pharmaceutical products. We also have specialists in Bayesian statistics, real world evidence, artificial intelligence, health economics, and a number of other research fields to ensure that academic and scientific findings can have impact on industry quickly and seamlessly. www.cytel.com
